medical device electronics News
-
VUNO Signs Another Deal with Samsung Electronics
VUNO Signs Another Deal with Samsung Electronics to Incorporate AI-assisted Solutions into Samsung’s Premium Ceiling Type Digital Radiography System October 6, 2021 – South Korean artificial intelligence (AI) developer, VUNO Inc., announced today that the company closed a deal with global medical device manufacturer, Samsung Electronics Co., Ltd., to embed VUNO’s artificial ...
By Vuno Inc.
-
Silver Bullet Therapeutics Secures CE Mark Approval for Revolutionary New Antimicrobial Bone Screw System
Silver Bullet Therapeutics, Inc., a privately-held medical device company, announced today that it has received recommendation for CE Mark approval for the commercial sale of its antimicrobial OrthoFuzIon™ Bone Screw System in the European Union for orthopedic reduction and internal fixation procedures anywhere in the body. Over the next few months, Silver Bullet will be finalizing launch ...
-
Case Western Reserve University, in Collaboration with NDI Medical, SPR Therapeutics and Valtronic Technologies, Receives $3 Million from Ohio Third Frontier Commission
Case Western Reserve University, in collaboration with NDI Medical LLC, SPR™ Therapeutics, and Valtronic, has been awarded a $3 million grant from the Ohio Third Frontier Commission to commercialize a neurostimulation technology platform designed to treat multiple clinical indications with significant unmet needs, including pain and muscle paralysis. The Ohio Third Frontier Innovation ...
-
DSM tenders Danisco shareholding
Royal DSM, the global Life Sciences and Materials Sciences company, announces that it has tendered its 4.95% stake in Danisco to DuPont. Upon completion of the DuPont offer of DKK 700 per ordinary Danisco share, DSM expects cash proceeds of € 222 million and to report a book profit of € 140 million before tax as an exceptional item. DSM - Bright Science. Brighter Living.(TM) Royal ...
By DSM
-
Joint statement by DSM and Nutreco regarding Provimi
Royal DSM and Nutreco note recent media speculation regarding a possible acquisition of Provimi. DSM and Nutreco confirm that for this purpose they have decided to jointly explore the possibility to acquire Provimi, should this opportunity arise. A further statement will only be made if and when appropriate. DSM - Bright Science. Brighter Living.(TM) Royal DSM N.V. is a global science-based ...
By DSM
-
DSM completes acquisition of Vitatene S.A.U.
Royal DSM, the global Life Sciences and Materials Sciences company, announces today that it has completed the acquisition of Vitatene S.A.U., based in León (Spain), a producer of natural carotenoids. The acquisition was announced on 10 May 2011. The acquisition of Vitatene allows DSM to strengthen the natural carotenoids offerings of its nutrition business as consumer demand for natural ...
By DSM
-
DSM renews €500 million credit facility
Royal DSM, the global Life Sciences and Materials Sciences company, today announces that it has entered into a committed credit facility of €500 million with certain credit relationship banks. This facility replaces a previous facility of the same amount which was scheduled to expire in October 2012. The unsecured credit facility of €500 million is for a minumum term of 5 years ...
By DSM
-
DSM appoints new Executive Vice President Corporate Strategy & Acquisitions
Royal DSM, the global Life Sciences and Materials Sciences company, today announces the following: Philip Eykerman, (1968), currently Partner at McKinsey & Company, Brussels office, will join DSM as Executive Vice President Corporate Strategy & Acquisitions, reporting to Feike Sijbesma, CEO and Chairman of the Managing Board of DSM. Philip will succeed Hein Schreuder, currently ...
By DSM
-
DSM completes sale of DSM Elastomers to LANXESS
Royal DSM, the global Life Sciences and Materials Sciences company, today announces that it has completed the sale of DSM Elastomers to LANXESS for € 310 million on a cash and debt-free basis. This completes the final stage of the transformation of DSM that began with the divestment program DSM announced in September 2007 as part of its Accelerated Vision 2010 program. After all ...
By DSM
-
DSM - proposed appointment to the Managing Board of Directors
The Supervisory Board of Royal DSM is pleased to announce that it will propose to the Annual General Meeting of Shareholders on 28 April 2011 to appoint Mr. Stefan Doboczky to the Managing Board of DSM with responsibility for DSM's Pharma cluster as well as the regional responsibility of DSM's activities in Asia, with effect from 1 May 2011. Mr. Doboczky will operate from two office locations, in ...
-
DSM appoints new Chief Technology Officer
Royal DSM, the global Life Sciences and Materials Sciences company, today announces the following: Marcel Wubbolts, currently Vice President R&D DSM Innovation Center, will assume the position of Chief Technology Officer for DSM as of October 1, reporting to Rob van Leen, Chief Innovation Officer. Marcel holds a PhD from the University of Groningen, NL, was post-doc and Assistent ...
By DSM
-
DSM completes acquisition of majority share in China-based UHMWPE fiber manufacturer
Royal DSM N.V. (DSM), the global Life Sciences and Materials Sciences company, today announced that it has successfully completed the acquisition of a majority share of 91.75% in Shandong ICD High Performance Fiber Co. Ltd. (ICD), based in Laiwu, Shandong province, China, as announced on 17 February 2011. Financial terms of the acquisition are not disclosed. ICD is a manufacturer of UHMWPE ...
By DSM
-
DSM announces management changes
Royal DSM, the global Life Sciences and Materials Sciences company, today announces the following: Jos Op Heij, currently Vice President Corporate Treasury, will take on the role of Senior Vice President Corporate Control and Accounting as of 1 August 2012, succeeding Loek Radix. Jos joined DSM in 1985 and holds a chartered controller degree. After positions in ICT, project management, demand ...
By DSM
-
DSM to acquire Vitatene S.A.U. to expand position in natural carotenoids
Royal DSM, the global Life Sciences and Materials Sciences company, announces today that it has signed an agreement with P&R Group (Italy) to acquire Vitatene S.A.U., based in León (Spain), a producer of natural carotenoids. The acquisition of Vitatene allows DSM to strengthen the natural carotenoids offerings of its nutrition business as consumer demand for natural products continues ...
By DSM
-
DSM updates market on strategy progress at Capital Markets Days
Royal DSM, the global Life Sciences and Materials Sciences company, today and tomorrow will update the financial community at its annual Capital Markets Days on the progress made with its DSM in Motion: driving focused growth strategy. The company also confirms its 2011 outlook. Feike Sijbesma, CEO and Chairman of the DSM Managing Board, commented: "Against a backdrop of increased ...
By DSM
-
DSM Successfully Completes Tender Offer for Martek and Expects to Complete Acquisition Today
Royal DSM N.V. (NYSE Euronext: DSM KON), the global Life Sciences and Materials Sciences company, announced today that it has successfully completed the subsequent offering period to its all-cash tender offer to purchase all of the outstanding shares of common stock of Martek Biosciences Corporation at a price of $31.50 per share. The previously announced subsequent offering period expired at ...
-
Collaboration in Innovation and Commercialization of Key Technologies Across the Pacific
Industrial Technology Research Institute (ITRI), Taiwan's largest and one of the world's leading high-tech research and development institutions, announces its 2012 ITRI Forum and Career Fair, Collaboration in Innovation and Commercialization Across the Pacific. The event, scheduled on June 25, 2012, at the Crowne Plaza Hotel in Milpitas, Calif., will draw Silicon Valley technology leaders, ...
-
DSM and Rostekhnologii to cooperate on biotechnology and functional materials
/www.w3.org/1999/xhtml">DSM and Rostekhnologii to cooperate on biotechnology and functional materials Royal DSM, the global Life Sciences and Materials Sciences company, announces today that it has signed a Memorandum of Understanding (MOU) for a strategic partnership with Rostekhnologii (Rostec), a Russian State Corporation, in the fields of biotechnology and functional materials. The MOU ...
By DSM
-
Royal DSM, World Vision announce partnership to nourish millions of the world´s most vulnerable children
/www.w3.org/1999/xhtml">Royal DSM, World Vision announce partnership to nourish millions of the world's most vulnerable children Working together to achieve lasting progress in global health and development by improving the nutritional status of mothers and children Flagship programme in Tanzania to fortify maize flour with essential micronutrients 22 May 2013 - Royal ...
By DSM
-
Exo Secures $220M in Series C Funding Round
Exo will commercialize an affordable handheld ultrasound device and workflow platform for a new era of medical care REDWOOD CITY, Calif. (July 29, 2021) — Exo (pronounced “echo”), a pioneering health information and devices company, closed a $220 million Series C investment round led by RA Capital Management and joined by BlackRock, Sands Capital, Avidity Partners and Pura Vida ...
By Exo
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you